Novartis is proud to share that CEO Vas Narasimhan, M.D., has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health.
Selected by TIME’s editors in collaboration with leading experts around the world, the list honors leaders across science, medicine, advocacy, education, and policy who are driving tangible, credible change for people around the world.
Vas is celebrated for his bold leadership at Novartis, where he has led a strategic transformation of the former health care conglomerate into a fully focused innovative medicines company. In the seven years since Vas became CEO, Novartis has developed innovative therapies across new technology platforms -- including siRNA, radioligand, and gene and cell therapies – that are changing the way patients with cardiovascular disease, cancer, and rare genetic disorders receive care.
A physician-scientist by training, Vas has overseen the licensure of more than 35 novel medicines and vaccines, while championing broader access to advanced therapies in low- and middle-income countries. His vision continues to shape how the industry tackles complex health challenges—with a focus on innovation, equity, and lasting change.
This recognition reflects not only his leadership but the collective commitment of Novartis teams who, through their expertise and passion, exemplify the company’s purpose of reimagining medicine, together—delivering breakthrough innovations that make a meaningful difference in the lives of patients worldwide.
The full TIME100 Health list and honoree profiles are available at time.com/time100health.